Home › Funds › Citigroup Inc › BCLI
Citigroup Inc position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q2 2025)663 sh
Reported value held$743
Portfolio Weight0.00%
First reportedQ4 2024
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.97K | $4.47K | New |
| Q2 2025 | 663 | $743 | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.